Skip to main content
SpringerLink
Log in

Do the Official Guidelines for Cardiac Resynchronization Therapy Need to Be Changed?

  • Chapter
Devices for Cardiac Resynchronization

  • 670 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lethbridge-Çejku M, Vickerie J. Summary health statistics for U.S. adults: National Health Interview Survey, 2003. National Center for Health Statistics. Washington DC. Vital Health Stat 10 (225). 2005.

    Google Scholar 

  2. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistic 2006 update. Circulation 2006;113: e85–e151.

    Google Scholar 

  3. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2002. Available at: www.acc.org/clinical/guidelines/pacemaker/pacemaker.pdf.

    Google Scholar 

  4. Stellbrink C, Breithardt OA, Franke A, et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957–65.

    Article  PubMed  CAS  Google Scholar 

  5. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873–80.

    Article  PubMed  CAS  Google Scholar 

  6. Stellbrink C, Breithardt OA, Franke A, et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957–65.

    Article  PubMed  CAS  Google Scholar 

  7. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–53.

    Article  PubMed  Google Scholar 

  8. Butter C, Auricchio A, Stellbrink C, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104:3026–9.

    Article  PubMed  CAS  Google Scholar 

  9. Linde C, Leclercq C, Rex S, et al. on behalf of the MUltisite STimulation In Cardiomyopathies (MUSTIC) Study Group. Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation In Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002;40:111–118.

    Article  PubMed  Google Scholar 

  10. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–50.

    Article  PubMed  CAS  Google Scholar 

  11. Cleland JG, Daubert JC, Erdmann E, et al. for the Cardiac Resynchronization–Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539–49.

    Article  PubMed  CAS  Google Scholar 

  12. McAlister F, Ezekowitz J, Wiebe N, et al. Cardiac resynchronization therapy for congestive heart failure. Evid Rep Technol Assess (Summ.) 2004;106:1–8.

    Google Scholar 

  13. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation endorsed by the Heart Rhythm Society. J Am Coll Cardiol 2005;46:1–82.

    Article  Google Scholar 

  14. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure a meta-analysis of randomized controlled trials. JAMA 2003;289:730–40.

    Article  PubMed  Google Scholar 

  15. Yu CM, Bleeker GB, Fung JW, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580–6.

    Article  PubMed  Google Scholar 

  16. Ghio S, Constantin C, Klersy C, et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 2004;25:571–8.

    Article  PubMed  Google Scholar 

  17. Auricchio A, Fantoni C, Regoli F, et al. Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation 2004;109:1133–9.

    Article  PubMed  Google Scholar 

  18. Bax JJ, Ansalone G, Breithardt OA, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 2004;44:1–9.

    Article  PubMed  Google Scholar 

  19. Yu CM, Fung JW, Zhang Q, et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodelling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 2004;110:66–73.

    Article  PubMed  Google Scholar 

  20. Yu CM, Abraham WT, Bax JJ, et al. Predictors of response to cardiac resynchronization therapy (PROSPECT)-study design. Am Heart J 2005;149:600–605.

    Article  PubMed  Google Scholar 

  21. Sogaard P, Eglebad H, Pedersen AK, et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure evaluation by tissue Doppler imaging. Circulation 2002;106:2078–84.

    Article  PubMed  Google Scholar 

  22. Abraham WT, Young JB, Smith AL et al., Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure the MIRACLE-ICD trial, Circulation 2004;110:2864–8.

    Article  PubMed  Google Scholar 

  23. Bleeker GB, Schalij MJ, Holman ER, et al. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2006;98:230–5

    Article  PubMed  Google Scholar 

  24. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction, Circulation 2003;23:2932–7.

    Article  Google Scholar 

  25. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 2002;288:3115–23.

    Article  PubMed  Google Scholar 

  26. Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927–37.

    Article  PubMed  Google Scholar 

  27. Maisel W, Stevenson L. Atrial fibrillation in heart failure epidemiology, pathophysiology and rationale for therapy. Am J Cardiol 2003;91:2D–8D.

    Article  PubMed  Google Scholar 

  28. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780–7.

    Article  PubMed  CAS  Google Scholar 

  29. Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258–63.

    Article  PubMed  Google Scholar 

  30. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study) J Cardiovasc Electrophysiol 2005;16:1160–5.

    Article  PubMed  Google Scholar 

  31. Gasparini M, Auricchio A, Regoli F. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression. The importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006;48:734–43.

    Article  PubMed  Google Scholar 

  32. Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54–60.

    Article  PubMed  Google Scholar 

  33. Søgaard P, Egeblad H, Kim WY, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:723–30.

    Article  PubMed  Google Scholar 

  34. Achilli A, Sassara M , Ficili S, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS. J Am Coll Cardiol 2003;42:2117–24.

    Article  PubMed  Google Scholar 

  35. Grigioni F, Enriquez-Sarano M, Zehr KJ, et al. Ischemic mitral regurgitation; long-term outcomes and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759–64

    PubMed  CAS  Google Scholar 

  36. Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002;105:438–45.

    Article  PubMed  Google Scholar 

  37. Egoavil CA, Ho RT, Greenspon AJ, et al. Cardiac resynchronization therapy in patients with right bundle branch block: Analysis of pooled data from the MIRACLE and Contak CD trials. Heart Rhythm 2005;2:611–5.

    Article  PubMed  Google Scholar 

  38. Aranda JM, Conti JB, Johnson JW, et al. Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: Analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Clin Cardiol 2004;27:678–82.

    Article  PubMed  Google Scholar 

  39. Reynolds MR, Joventino LP, Josephson ME, et al. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure. Pacing Clin Electrophysiol 2004;27:1513–8.

    Article  PubMed  Google Scholar 

  40. Eldadah DA, Rosen B, Hay I, et al. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging. Heart Rhythm 2006;3:435–42.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Nadim G. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne B. Curtis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bengt Herweg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Serge Barold
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Professor of Medicine, University of South Florida College of Medicine and Division of Cardiology Tampa General Hospital, Tampa, Florida, USA

    S. Serge Barold MD, FRACP, FACP FACC, FESC, FHRS

  2. Chairman, Cardiostim InParys, St Cloud Clinique Bizet, Paris Clinique Chirurgicale Val d’Or, St Cloud, Paris, France

    Philippe Ritter MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Khan, N.G., Curtis, A.B., Herweg, B., Barold, S.S. (2008). Do the Official Guidelines for Cardiac Resynchronization Therapy Need to Be Changed?. In: Barold, S.S., Ritter, P. (eds) Devices for Cardiac Resynchronization. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-71167-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-71167-6_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-71166-9

  • Online ISBN: 978-0-387-71167-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation